Literature DB >> 19904897

Nephrotic syndrome in adults: diagnosis and management.

Charles Kodner1.   

Abstract

Nephrotic syndrome may be caused by primary (idiopathic) renal disease or by a variety of secondary causes. Patients present with marked edema, proteinuria, hypoalbuminemia, and often hyperlipidemia. In adults, diabetes mellitus is the most common secondary cause, and focal segmental glomerulosclerosis and membranous nephropathy are the most common primary causes. Venous thromboembolism is a possible complication; acute renal failure and serious bacterial infection are also possible, but much less common. There are no established guidelines on the diagnostic workup or management of nephrotic syndrome. Imaging studies are generally not needed, and blood tests should be used selectively to diagnose specific disorders rather than for a broad or unguided workup. Renal biopsy may be useful in some cases to confirm an underlying disease or to identify idiopathic disease that is more likely to respond to corticosteroids. Treatment of most patients should include fluid and sodium restriction, oral or intravenous diuretics, and angiotensin-converting enzyme inhibitors. Some adults with nephrotic syndrome may benefit from corticosteroid treatment, although research data are limited. Intravenous albumin, prophylactic antibiotics, and prophylactic anticoagulation are not currently recommended.

Entities:  

Mesh:

Year:  2009        PMID: 19904897

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  12 in total

1.  Prolonged PT and aPTT in a patient with severe proteinuria.

Authors:  Irene Motta; Andrea Artoni; Margherita Migone De Amicis; Cinzia Hu; Maria Domenica Cappellini
Journal:  Intern Emerg Med       Date:  2013-08-09       Impact factor: 3.397

2.  Keeping nephrotic syndrome on the emergency department edema differential: A case report.

Authors:  Joshua Goodwin; Bijon Das
Journal:  World J Emerg Med       Date:  2019

Review 3.  Management of nephrotoxicity of chemotherapy and targeted agents: 2020.

Authors:  Varsha Chiruvella; Pavan Annamaraju; Achuta K Guddati
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

Review 4.  Soy-based renoprotection.

Authors:  Nancy J McGraw; Elaine S Krul; Elizabeth Grunz-Borgmann; Alan R Parrish
Journal:  World J Nephrol       Date:  2016-05-06

5.  A Novel CLCN5 Splice Site Mutation in a Boy with Incomplete Phenotype of Dent Disease.

Authors:  Maria Bitsori; Eleni Vergadi; Emmanouil Galanakis
Journal:  J Pediatr Genet       Date:  2019-06-04

6.  Deflazacort in comparison to other steroids for nephrotic syndrome.

Authors:  K R Jat; A Khairwa
Journal:  Indian J Nephrol       Date:  2012-07

7.  Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy.

Authors:  Shin Hye Yoo; Hyean-Ji Kim; Jeong-Han Kim; Gyeong-Won Lee; Jeong Hee Lee; Se Hyun Kim; Ji-Won Kim; Jin Won Kim; Jeong-Ok Lee; Yu Jung Kim; Keun-Wook Lee; Jee Hyun Kim; Soo-Mee Bang; Jong Seok Lee
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

8.  Risk factors for renal involvement and severe kidney disease in 2731 Chinese children with Henoch-Schönlein purpura: A retrospective study.

Authors:  Ke Wang; Xiaomei Sun; Yang Cao; Liang Dai; Feiyang Sun; Ping Yu; Liqun Dong
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

9.  Analysis and Study on Epidemiological Features and Prognosis of Nephrotic Syndrome in Xinjiang and Heilongjiang.

Authors:  Jizhang Liu; Yuxia Zhong; Liangduan Ding; Ayinuer Tuluhong; Burebi Maihemuti; Tianxiong Pan; Mingjie Wu; Hailong Chen; Chen Lu
Journal:  Comput Math Methods Med       Date:  2021-11-24       Impact factor: 2.238

10.  Carotid thromboembolism associated with nephrotic syndrome treated with dabigatran.

Authors:  Yosuke Sasaki; Yoshihiko Raita; Genta Uehara; Yasushi Higa; Hitoshi Miyasato
Journal:  Case Rep Nephrol Urol       Date:  2014-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.